Insider Selling: Prestige Consumer Healthcare Inc. (NYSE:PBH) CEO Sells 10,875 Shares of Stock

Prestige Consumer Healthcare Inc. (NYSE:PBH) CEO Ronald M. Lombardi sold 10,875 shares of the company’s stock in a transaction that occurred on Tuesday, November 19th. The shares were sold at an average price of $82.60, for a total value of $898,275.00. Following the sale, the chief executive officer now owns 320,952 shares in the company, valued at $26,510,635.20. The trade was a 3.28 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Prestige Consumer Healthcare Price Performance

Shares of PBH stock traded up $1.47 during trading hours on Thursday, hitting $84.14. 286,632 shares of the company’s stock were exchanged, compared to its average volume of 251,540. Prestige Consumer Healthcare Inc. has a 12-month low of $56.61 and a 12-month high of $84.21. The company has a market capitalization of $4.16 billion, a PE ratio of 20.11, a PEG ratio of 2.32 and a beta of 0.47. The company has a current ratio of 3.56, a quick ratio of 2.10 and a debt-to-equity ratio of 0.61. The business’s 50 day simple moving average is $73.91 and its 200-day simple moving average is $70.48.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, November 7th. The company reported $1.09 earnings per share for the quarter, meeting the consensus estimate of $1.09. The company had revenue of $283.79 million during the quarter, compared to the consensus estimate of $282.09 million. Prestige Consumer Healthcare had a net margin of 18.54% and a return on equity of 12.23%. The firm’s quarterly revenue was down .9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.07 earnings per share. On average, equities research analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.45 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. Opal Wealth Advisors LLC acquired a new position in Prestige Consumer Healthcare during the second quarter worth $26,000. Quest Partners LLC lifted its position in shares of Prestige Consumer Healthcare by 2,826.7% during the 2nd quarter. Quest Partners LLC now owns 439 shares of the company’s stock worth $30,000 after buying an additional 424 shares during the last quarter. EverSource Wealth Advisors LLC raised its stake in Prestige Consumer Healthcare by 80.6% during the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock valued at $33,000 after acquiring an additional 208 shares during the last quarter. Gladius Capital Management LP acquired a new stake in shares of Prestige Consumer Healthcare during the 2nd quarter valued at approximately $35,000. Finally, Northwestern Mutual Wealth Management Co. boosted its stake in shares of Prestige Consumer Healthcare by 562.3% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company’s stock valued at $35,000 after acquiring an additional 433 shares during the last quarter. 99.95% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

PBH has been the subject of a number of analyst reports. Jefferies Financial Group restated a “hold” rating and issued a $76.00 price objective (up from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. DA Davidson reiterated a “buy” rating and set a $95.00 target price on shares of Prestige Consumer Healthcare in a report on Monday, November 11th. One equities research analyst has rated the stock with a hold rating and three have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $83.67.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.